Overview
Indications
Praziquantel tablets are indicated in patients aged 1 year and older for the treatment of the following infections: Schistosoma mekongi, Schistosoma japonicum, Schistosoma mansoni and Schistosoma hematobium Schistosomiasis due to all species of schistosoma (for example,), and Clonorchis sinensis/Opisthorchis viverrini Clonorchiasis and Opisthorchiasis due to the liver flukes,(approval of this indication was based on studies in which the two species were not differentiated)
Contraindications
When this intervention should not be used
Praziquantel is contraindicated in: Patients who previously have shown hypersensitivity to praziquantel or any of the excipients in praziquantel tablets. Patients with ocular cysticercosis; since parasite destruction within the eye that occurs because of hypersensitivity reaction to the dead parasit
Indications & Related Conditions
Conditions associated via SNOMED clinical relationships
Administration & Protocol
Dosing, route, and treatment protocol
Detailed dosage and administration information is available in the full FDA drug label.
View full prescribing information on DailyMedMonitoring & Follow-Up
Biomarkers relevant to this intervention via related conditions
No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.
Clinical Trials
8 trials linked to this intervention
Recent Trials
Host Response to Infection and Treatment in Filarial Diseases
Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Efficacy of Albendazole to Treat Intestinal Helminths and Its Effect on Gut Microflora
The Effect of a Deworming Intervention to Improve Early Childhood Growth and Development in Resource-poor Areas
Postpartum Deworming: Improving Breastfeeding and Optimizing Infant Growth
Research Evidence
Published studies and systematic reviews
Research data from MEDLINE/PubMed
Benefits & Expected Outcomes
Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.
Risks & Side Effects
Adverse reaction and safety data for this drug is sourced from the FDA-approved label.
View adverse reactions & drug interactions on DailyMedRelated Symptoms
Symptoms associated with conditions this intervention addresses
No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.
Alternatives & Comparisons
Alternative treatments, comparison data, and clinical decision support are pending physician authorship.
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Do not start, stop, or change any treatment without consulting your healthcare provider.
Quick Facts
- Type
- Substance / Medication
- Fully Specified Name
- Praziquantel (substance)
- SNOMED CT
- 387310003
- UMLS CUI
- C0032911
- RxNorm CUI
- 8628
- Labeler
- Endo USA, Inc.
Clinical Data
This intervention maps to 8 entities in the Ltrl knowledge graph.
Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.